Atrial electrophysiological and structural remodeling in high-risk patients with Brugada syndrome: Assessment with electrophysiology and echocardiography

Heart Rhythm

Volumn 7, Issue 2, 2010, Pages 218-224

  Toh, Norihisa ^a   Morita, Hiroshi ^a   Nagase, Satoshi ^a   Taniguchi, Manabu ^b   Miura, Daiji ^a   Nishii, Nobuhiro ^a   Nakamura, Kazufumi ^a   Ohe, Tohru ^c   Kusano, Kengo F ^a   Ito, Hiroshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^c THE SAKAKIBARA HEART INSTITUTE OF OKAYAMA   (Japan)

Author keywords

Atrial fibrillation; Echocardiography; Genes; Remodeling; Sudden cardiac death

Indexed keywords

SODIUM CHANNEL; SODIUM CHANNEL NAV1.5;

ADULT; ARTICLE; BRUGADA SYNDROME; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY SINUS; ECHOCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; GENE MUTATION; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART VENTRICLE FIBRILLATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MORPHOLOGY; PRIORITY JOURNAL; SYSTOLE;

ATRIAL FIBRILLATION; BRUGADA SYNDROME; CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE PROTEINS; SODIUM CHANNELS;

EID: 74549185123     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.10.035     Document Type: Article

References (21)

1. Antzelevitch C., Brugada P., Borggrefe M., et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 111 (2005) 659-670
2. Brugada J., Brugada R., and Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation 97 (1998) 457-460
3. Brugada P., and Brugada J. Right bundle branch block, persistent ST-segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20 (1992) 1391-1396
4. Takenaka S., Kusano K.F., Hisamatsu K., et al. Relatively benign clinical course in asymptomatic patients with Brugada-type electrocardiogram without family history of sudden death. J Cardiovasc Electrophysiol 12 (2001) 2-6
5. Morita H., Kusano-Fukushima K., Nagase S., et al. Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. J Am Coll Cardiol 40 (2002) 1437-1444
6. Kusano K.F., Taniyama M., Nakamura K., et al. Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds. J Am Coll Cardiol 51 (2008) 1169-1175
7. Corrado D., Nava A., Buja G., et al. Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol 27 (1996) 443-448
8. Takagi M., Aihara N., Kuribayashi S., et al. Abnormal response to sodium channel blockers in patients with Brugada syndrome: augmented localised wall motion abnormalities in the right ventricular outflow tract region detected by electron beam computed tomography. Heart 89 (2003) 169-174
9. Catalano O., Antonaci S., Moro G., et al. Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities. Eur Heart J 30 (2009) 2241-2248
10. Frustaci A., Priori S.G., Pieroni M., et al. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 112 (2005) 3680-3687
11. Coronel R., Casini S., Koopmann T.T., et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation 112 (2005) 2769-2777
12. Miura D., Nakamura K., and Ohe T. Update on genetic analysis in Brugada syndrome. Heart Rhythm 5 (2008) 1495-1496
13. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
14. Dokainish H., Zoghbi W.A., Lakkis N.M., et al. Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation 109 (2004) 2432-2439
15. Bigi M.A., Aslani A., and Shahrzad S. Clinical predictors of atrial fibrillation in Brugada syndrome. Europace 9 (2007) 947-950
16. Abhayaratna W.P., Seward J.B., Appleton C.P., et al. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol 47 (2006) 2357-2363
17. Appleton C.P., Galloway J.M., Gonzalez M.S., Gaballa M., and Basnight M.A. Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease. Additional value of analyzing left atrial size, left atrial ejection fraction and the difference in duration of pulmonary venous and mitral flow velocity at atrial contraction. J Am Coll Cardiol 22 (1993) 1972-1982
18. Chen Q., Kirsch G.E., Zhang D., et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392 (1998) 293-296
19. Schott J.J., Alshinawi C., Kyndt F., et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 23 (1999) 20-21
20. Makiyama T., Akao M., Shizuta S., et al. A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol 52 (2008) 1326-1334
21. McNair W.P., Ku L., Taylor M.R., et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 110 (2004) 2163-2167